These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Author: Cutler K, Kagen MH, Don PC, McAleer P, Weinberg JM.
    Journal: Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136.
    Abstract:
    Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.
    [Abstract] [Full Text] [Related] [New Search]